La anemia hemolítica autoinmune (AHAI) es una enfermedad poco frecuente en la edad pediátrica. Su diagnóstico se establece mediante la prueba de. La asociación de colitis ulcerosa (CU) y anemia hemolítica autoimmune (AHAI) se describió por primera vez a principios de la década de los cincuenta; sin. Se estudiaron 13 pacientes con leucemia mieloide crónica y anemia hemolítica autoinmune inducida por el interferón alfa, a quienes se les realizó la detección.
|Published (Last):||25 June 2010|
|PDF File Size:||4.64 Mb|
|ePub File Size:||14.49 Mb|
|Price:||Free* [*Free Regsitration Required]|
The James Blundell Award Lecture July – August Pages Are you a health professional able to prescribe or dispense drugs? Successful induction and maintenance of long-term remission in a child with chronic relapsing autoinmune hemolytic anemia using rituximab.
Autoinmune hemolytic anemia during interferon treatment in nine patients with hematological diseases. Continuing navigation will be considered as acceptance of this use.
Recently, rituximab has been shown to be an alternative treatment option in children as well as in adults for relapsed and refractory autoimmune haemolytic anaemias and in patients who are medically unsuited for espenectomy.
SRJ is a prestige metric based on the idea that not all citations are the same. Pediatd Hematol Oncol, 20pp. Interferon in chronic myeloid leukaemia: The role of rituximab in adults with warm antibody autoimmune hemolytic anaemia. To improve our services and products, we use “cookies” own or third parties authorized to show advertising related to client preferences through the analyses of navigation customer behavior. The hemopitica of action appears to be linked with the selective B-cell depletion and the lowering of autoantibody levels.
Inmunologia celular y molecular.
DESTACAN LA UTILIDAD DEL RITUXIMAB PARA TRATAR LA ANEMIA HEMOLITICA AUTOIMMUNE
Petz LD, Garraty G. ApartadoCP Rev Cubana Hematol Inmunol Hemoter.
SJR uses a similar algorithm as the Google page rank; it provides a quantitative and qualitative measure of the journal’s impact. Retrospective analysis of 27 cases. Lupus, 24pp.
Normal outcome of pregnancy in chronic myeloid leukemia hfmolitica with interferon-alpha in 1st trimester: A variety of other immunosuppressive agents as well as splenectomy are used for refractory cases.
La PAD y la Mp fueron negativas en un caso. SNIP measures contextual citation impact by wighting citations based on the total number of citations in a subject field.
There was a problem providing the content you requested
Rev Cub Hematol Inmunol Hemoter. Is a -methyldopa-type anejia hemolytic anemia mediated by interferon- anemis They underwent tests for immune protein detection and characterization of IgG subclasses in RBCs by direct antiglobulin test PAD and the microplate technique. The treatment of cold agglutinin disease consists of avoiding cold environments, inmunosuppresive therapy and more recently rituximab.
CiteScore measures average citations received per document published. You can change the settings or obtain more information by clicking here. Treatment of AIHA, especially in cold antibody-mediated disease, represents a therapeutical challenge.
Anemia Hemolítica Autoinmune | Medical City McKinney
Jonasch E, Haluska FG. Rituximab in Refractory Autoimmune Hemolytic Anemia in Rituximab therapy has a rapid and durable response for refractory cytopenia in childhood-onset systemic lupus erythematosus. Key autoinmmune autoimmune haemolytic anaemia, cold agglutinin disease, rituximab.
Quantitation aspect of destruction of red cell autoinmume with IgG1 autoantibodies an aplication of flow cytofluorometry. Br J Clin Pharmacol, 79pp. Am J Hematol, 84pp.
Abstract Autoimmune haemolytic anaemia AIHA is an immune haematologic disorder resulting from autoantibody production directed against red-cell antigens. Immune-mediated and unusual complications during interferon alpha therapy in chronic myelogenous leukemia. Subscribe to our Newsletter. In high-grade hemolysis patients, it was found a concentration of autoantibodies between 1 anwmia 3 molecules of IgG per erythrocyte, while in low-grade hemolysis patients it behaved between and 1 molecules.
Estos resultados son similares a los obtenidos en los pacientes con AHAI y en la anemia autoinmune secundaria al tratamiento con alfa metildopa.